Pharma industry shuns Trump push for radical shift at FDA

(Reuters) - U.S. President Donald Trump's vow to roll back government regulations at least 75 percent is causing anxiety for some pharmaceutical executives that a less robust Food and Drug Administration would make it harder to secure insurance coverage for pricey new medicines.

Pharma industry shuns Trump push for radical shift at FDA
Read More


Bagikan Berita Ini